Metin Kurtoglu has sold RNAC and made no open-market buys since Nov 2024
CTO at Cartesian Therapeutics, Inc.
SEC CIK 0002000284 · Filings on SEC.gov ↗
$0Bought
$2.1MSold
NoneLast buy
Every filing
2 filings since Nov 2024, newest first
Filings come from SEC EDGAR. Not investment advice.